Pharmaron Issues Online Release of 2025 AGM Circular, Notice and Proxy Form

Bulletin Express05-21 17:04

Pharmaron Beijing Co., Ltd. issued a shareholder notification on 21 May 2026 confirming that three key documents for the forthcoming 2025 Annual General Meeting (AGM)—the Circular, the Notice of Meeting and the Proxy Form—have been published on both the company website (www.pharmaron.com) and the Hong Kong Stock Exchange website (www.hkexnews.hk).

The notification applies to H-shareholders who previously elected, or were deemed to have consented, to receive corporate communications electronically. Those unable to access the online files may request printed copies free of charge by submitting a Request Form to the company’s H-share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.

Shareholders may alter at any time their preferred method of receiving future corporate communications—choosing between printed English, printed Chinese, bilingual print or web-based versions—by emailing 3759-ecom@vistra.com or by written notice to the registrar.

For further enquiries, Pharmaron has provided a hotline at (852) 2980 1333, operating Monday to Friday, 9:00 a.m. to 5:00 p.m. (Hong Kong time), excluding public holidays.

The notification was released under the authority of Dr. Lou Boliang, Chairman of Pharmaron Beijing Co., Ltd.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1102410707?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-21 17:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102410707","market":"us","top_or_hot":-1,"title":"Pharmaron Issues Online Release of 2025 AGM Circular, Notice and Proxy Form","media":"Bulletin Express","content":"<p>Pharmaron Beijing Co., Ltd. issued a shareholder notification on 21 May 2026 confirming that three key documents for the forthcoming 2025 Annual General Meeting (AGM)—the Circular, the Notice of Meeting and the Proxy Form—have been published on both the company website (www.pharmaron.com) and the Hong Kong Stock Exchange website (www.hkexnews.hk).</p>\n<p>The notification applies to H-shareholders who previously elected, or were deemed to have consented, to receive corporate communications electronically. Those unable to access the online files may request printed copies free of charge by submitting a Request Form to the company’s H-share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.</p>\n<p>Shareholders may alter at any time their preferred method of receiving future corporate communications—choosing between printed English, printed Chinese, bilingual print or web-based versions—by emailing 3759-ecom@vistra.com or by written notice to the registrar.</p>\n<p>For further enquiries, Pharmaron has provided a hotline at (852) 2980 1333, operating Monday to Friday, 9:00 a.m. to 5:00 p.m. (Hong Kong time), excluding public holidays.</p>\n<p>The notification was released under the authority of Dr. Lou Boliang, Chairman of Pharmaron Beijing Co., Ltd.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaron Issues Online Release of 2025 AGM Circular, Notice and Proxy Form</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaron Issues Online Release of 2025 AGM Circular, Notice and Proxy Form\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-21 17:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaron Beijing Co., Ltd. issued a shareholder notification on 21 May 2026 confirming that three key documents for the forthcoming 2025 Annual General Meeting (AGM)—the Circular, the Notice of Meeting and the Proxy Form—have been published on both the company website (www.pharmaron.com) and the Hong Kong Stock Exchange website (www.hkexnews.hk).</p>\n<p>The notification applies to H-shareholders who previously elected, or were deemed to have consented, to receive corporate communications electronically. Those unable to access the online files may request printed copies free of charge by submitting a Request Form to the company’s H-share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.</p>\n<p>Shareholders may alter at any time their preferred method of receiving future corporate communications—choosing between printed English, printed Chinese, bilingual print or web-based versions—by emailing 3759-ecom@vistra.com or by written notice to the registrar.</p>\n<p>For further enquiries, Pharmaron has provided a hotline at (852) 2980 1333, operating Monday to Friday, 9:00 a.m. to 5:00 p.m. (Hong Kong time), excluding public holidays.</p>\n<p>The notification was released under the authority of Dr. Lou Boliang, Chairman of Pharmaron Beijing Co., Ltd.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1102410707","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102410707","pubTimestamp":1779354257,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Pharmaron Beijing Co., Ltd. issued a shareholder notification on 21 May 2026 confirming that three key documents for the forthcoming 2025 Annual General Meeting (AGM)—the Circular, the Notice of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"康龙化成在线发布2025年股东周年大会通函、通知和代表委任表格","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"Pharmaron Beijing Co., Ltd. issued a shareholder notification on 21 May 2026 confirming that three key documents for the forthcoming 2025 Annual General Meeting (AGM)—the Circular, the Notice of Meeting and the Proxy Form—have been published on both the company website (www.pharmaron.com) and the Hong Kong Stock Exchange website (www.hkexnews.hk).\nThe notification applies to H-shareholders who previously elected, or were deemed to have consented, to receive corporate communications electronically. Those unable to access the online files may request printed copies free of charge by submitting a Request Form to the company’s H-share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.\nShareholders may alter at any time their preferred method of receiving future corporate communications—choosing between printed English, printed Chinese, bilingual print or web-based versions—by emailing 3759-ecom@vistra.com or by written notice to the registrar.\nFor further enquiries, Pharmaron has provided a hotline at (852) 2980 1333, operating Monday to Friday, 9:00 a.m. to 5:00 p.m. (Hong Kong time), excluding public holidays.\nThe notification was released under the authority of Dr. Lou Boliang, Chairman of Pharmaron Beijing Co., Ltd.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1102410707","isCrawlerRequest":true}